Rice Acquisition Corp. II, a special purpose acquisition company (SPAC), and American clean energy producer NET Power will merge their businesses to accelerate decarbonization of natural gas power generation. Called NET Power Inc., the combined business is projected to have an enterprise value of $1.46 billion and to capture substantial market share with planned utility-scale […]
Woolworths, an Australian trans-Tasman retailer, has agreed to acquire 55% of interest in Petspiration, a pet food retailer, for an enterprise value of approximately AUD 1.7 billion, assuming net debt of around AUD 670 million. The acquisition is expected to increase Woolworths’ presence in the pet retail space. Petspiration owns and runs PETstock, a retail […]
GRI Bio, a privately held clinical stage biotech company, will merge with a wholly-owned subsidiary of Nasdaq-listed Vallon Pharmaceuticals in an all-stock transaction. The combined entity is expected to operate as GRI Bio, Inc., and advance GRI Bio’s pipeline of natural killer T (NKT) cell regulators for the treatment of multiple inflammatory, autoimmune, and fibrotic […]
Tandem Diabetes Care, an American diabetes technology company, has agreed to acquire Switzerland-based insulin patch pump developer AMF Medical SA for CHF 62.4 million, which includes a previous strategic investment of CHF 8 million and a cash consideration of CHF 62.4 million at closing. As per the terms of the agreement, AMF Medical is also […]
Novartis has received the approval of the European Commission (EC) for Pluvicto (lutetium (177Lu) vipivotide tetraxetan), a targeted radioligand therapy for advanced prostate cancer. Following the approval, Pluvicto has become the first targeted radioligand therapy to be commercially available to prevent advanced prostate cancer in individuals. Pluvicto in combination with androgen deprivation therapy (ADT) with […]
Wave Life Sciences and GSK have forged a partnership to discover and develop oligonucleotide therapeutics, focusing on new genetic targets, for respiratory diseases. The discovery collaboration with an initial four-year research term is expected to advance Wave Life Sciences’ preclinical RNA editing program, WVE-006, to treat alpha-1 antitrypsin deficiency (AATD), a disease that impacts the […]
Private equity firm Stellex Capital Management, through its affiliate, has agreed to acquire G2 Web Services, Lundquist Consulting, and Fintellix India from TransUnion, a US-based consumer credit reporting agency, for $176 million. The consideration includes $104 million of cash and a $72 million note to be issued with a duration of up to three years. […]
Equinor Energy has started production from phase 1 of the Askeladd gas and condensate field in the Barents Sea, thereby increasing plateau production from the Hammerfest LNG plant on Melkøya Island, Norway, for about three years. Delivered on schedule, the development of the Askeladd field phase 1 eventually cost NOK 650 million ($67 million) less […]
Amgen through its wholly-owned subsidiary Pillartree has agreed to acquire Ireland-based biopharmaceutical firm Horizon Therapeutics for an enterprise value of around $28.3bn. The US biotechnology company will pay $116.5 per share in cash, which is a premium of around 19.7% to Horizon Therapeutics’ closing stock price of $97.29 per share on 9 December 2022. Horizon […]
Thoma Bravo, an American software investment firm, has agreed to acquire Coupa Software, a cloud-based business spend management platform listed on Nasdaq, for an enterprise value of $8bn. Coupa Software platform integrates processes across supply chain, procurement, and finance functions as well as enables enterprises to maximize value and operationalize purpose through their business spend. […]